Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,387.60 +52.30 0.34%
S&P 500 1,669.16 +2.87 0.17%
Nasdaq 3,502.12 +5.69 0.16%
Ticker Volume Price Price Delta
STOXX 50 2,825.17 +3.52 0.12%
FTSE 100 6,794.40 -9.47 -0.14%
DAX 8,469.58 -2.62 -0.03%
Ticker Volume Price Price Delta
Nikkei 15,627.30 +246.24 1.60%
Hang Seng 23,237.20 -129.17 -0.55%
S&P/ASX 200 5,165.37 -14.69 -0.28%
  • Exchange: Tel Aviv
  • Sector: Consumer, Non-cyclical
  • Industry: Pharmaceuticals
  • Sub-Industry: Medical-Generic Drugs

Teva Pharmaceutical Industries Ltd

+ Add to Watchlist

TEVA:IT

14,690.00 ILs 20.00 0.14%

As of 03:03:32 ET on 05/22/2013.

Company Profile for Teva Pharmaceutical Industries Ltd (TEVA)

Teva Pharmaceutical Industries Ltd., is a global pharmaceutical company. The Company develops, manufactures, and markets generic and branded human pharmaceuticals as well as active pharmaceutical ingredients.

Contact Information

Teva Pharmaceutical Industries Ltd

5 Basel Street
PO Box 3190
Petach Tikva
Israel
Phone: 972-3-914-8171
Fax: 972-3-914-8678

Key Executives for Teva Pharmaceutical Industries Ltd (TEVA)

Phillip FrostChairmanJeremy M LevinPresident/CEO
Allan ObermanPresident & CEO:AmericasRobert Koremans "Rob"President & CEO:Europe
Carlo De NotaristefaniPresident & CEO:Global OpsJudith VardiPresident & CEO:Emia & Asia Pacific
Michael R HaydenPres:Global R&D/Chief Scientific OfcrEyal DeshehGroup Exec VP/CFO
Richard S EgosiGroup Exec VP/Chief Legal Ofcr/SecyPaul J SekhriGroup Exec VP:Global/Chief Strategy Ofcr
Aharon Yaari "Arik"Group Exec VP:InstitutionalIsaac Abravanel "Ica"Group Exec VP:Human Resources
Kevin C MannixVP/Head:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil